With regards to the higher females’ prevalence in the progressors group, the biological plausibility may be explained by the recent findings that demonstrated that cardiac glucose metabolism of insulin-resistant females is significantly reduced in comparison with men, as a consequence of a specific and early myocardial insulin-resistance [23,24]. The gene discussed is INS; the disease is Insulin resistance.